Literature DB >> 2093690

Serum and urine levels of tumour necrosis factor in patients with genitourinary cancer and their relevance to disease status.

A Akdaş1, L Türkeri, T Akoğlu.   

Abstract

Serum and urine levels of tumour necrosis factor (TNF) which is a lymphokine was measured in patients with genitourinary cancer (either prostatic, bladder or testicular carcinoma) in order to find out whether there were elevated levels of TNF in those patients and if it was related to disease status. Although the preliminary results are not conclusive, further research on TNF may prove this immunoprotein to be a potential diagnostic and therapeutic agent.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2093690     DOI： 10.1007/BF02549736

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN： 0301-1623            Impact factor:   2.370


  13 in total

1.  Tumor necrosis factor in humans.

Authors:  E J Ziegler
Journal:  N Engl J Med       Date:  1988-06-09       Impact factor: 91.245

Review 2.  Cachectin: more than a tumor necrosis factor.

Authors:  B Beutler; A Cerami
Journal:  N Engl J Med       Date:  1987-02-12       Impact factor: 91.245

3.  An endotoxin-induced serum factor that causes necrosis of tumors.

Authors:  E A Carswell; L J Old; R L Kassel; S Green; N Fiore; B Williamson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

4.  Receptor binding and activation of polymorphonuclear neutrophils by tumor necrosis factor-alpha.

Authors:  M R Shalaby; M A Palladino; S E Hirabayashi; T E Eessalu; G D Lewis; H M Shepard; B B Aggarwal
Journal:  J Leukoc Biol       Date:  1987-03       Impact factor: 4.962

5.  Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon.

Authors:  B B Aggarwal; T E Eessalu; P E Hass
Journal:  Nature       Date:  1985 Dec 19-1986 Jan 1       Impact factor: 49.962

6.  Detection of circulating tumor necrosis factor after endotoxin administration.

Authors:  H R Michie; K R Manogue; D R Spriggs; A Revhaug; S O'Dwyer; C A Dinarello; A Cerami; S M Wolff; D W Wilmore
Journal:  N Engl J Med       Date:  1988-06-09       Impact factor: 91.245

7.  Characterization of specific high affinity receptors for human tumor necrosis factor on mouse fibroblasts.

Authors:  P E Hass; A Hotchkiss; M Mohler; B B Aggarwal
Journal:  J Biol Chem       Date:  1985-10-05       Impact factor: 5.157

8.  Antitumour effects of tumour necrosis factor: cytotoxic or necrotizing activity and its mechanism.

Authors:  K Haranaka; N Satomi; A Sakurai; R Haranaka
Journal:  Ciba Found Symp       Date:  1987

9.  Raised serum levels of tumour necrosis factor in parasitic infections.

Authors:  P Scuderi; K E Sterling; K S Lam; P R Finley; K J Ryan; C G Ray; E Petersen; D J Slymen; S E Salmon
Journal:  Lancet       Date:  1986-12-13       Impact factor: 79.321

10.  Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells.

Authors:  B Beutler; J Mahoney; N Le Trang; P Pekala; A Cerami
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.